Cargando…
Impact of aprotinin and renal function on mortality: a retrospective single center analysis
BACKGROUND: An estimated up to 7% of high-risk cardiac surgery patients return to the operating room for bleeding. Aprotinin was used extensively as an antifibrinolytic agent in cardiac surgery patients for over 15 years and it showed efficacy in reducing bleeding. Aprotinin was removed from the mar...
Autores principales: | Schloss, Brian, Gulati, Parul, Yu, Lianbo, Abdel-Rasoul, Mahmoud, O'Brien, William, Von Visger, Jon, Awad, Hamdy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178482/ https://www.ncbi.nlm.nih.gov/pubmed/21878108 http://dx.doi.org/10.1186/1749-8090-6-103 |
Ejemplares similares
-
Identification of an aprotinin antiviral domain
por: Pellegrini, Antonio, et al.
Publicado: (1994) -
Anti-tumour Activity of Aprotinin
por: Latner, A. L., et al.
Publicado: (1974) -
Antifibrinolytic Agents: Aprotinin, and Desmopressin
por: Bajaj, Pramila
Publicado: (2009) -
Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis
por: Sander, Michael, et al.
Publicado: (2010) -
Renal effects of the serine protease inhibitor aprotinin in healthy conscious mice
por: Wörner, Stefan, et al.
Publicado: (2021)